Technical Analysis for EKF - Ekf Diagnostics Holdings Plc

Grade Last Price % Change Price Change
D 68.0 -2.86% -2.00
EKF closed down 2.86 percent on Tuesday, May 11, 2021, on 71 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical EKF trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -2.86%
Outside Day Range Expansion -2.86%
Oversold Stochastic Weakness -2.86%
Lower Bollinger Band Walk Weakness -3.41%
Multiple of Ten Bullish Other -3.41%
Lower Bollinger Band Touch Weakness -3.41%
Oversold Stochastic Weakness -3.41%
Lower Bollinger Band Walk Weakness -2.30%
Older End-of-Day Signals for EKF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Ekf Diagnostics Holdings Plc Description

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Manufacturing Science Medicine Monitoring Life Sciences Disease Diseases Beta Clinical Medicine Biomarker Infectious Infectious Disease Enzymes Infectious Diseases Ancillary Products Diabetes Ekf Blood Tests Ekf Diagnostics Ivd Medical Tests

Is EKF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 83.0
52 Week Low 41.0
Average Volume 718,677
200-Day Moving Average 65.79
50-Day Moving Average 72.77
20-Day Moving Average 75.73
10-Day Moving Average 72.10
Average True Range 3.82
ADX 29.25
+DI 9.16
-DI 18.15
Chandelier Exit (Long, 3 ATRs ) 71.54
Chandelier Exit (Short, 3 ATRs ) 79.46
Upper Bollinger Band 84.42
Lower Bollinger Band 67.04
Percent B (%b) 0.06
BandWidth 22.95
MACD Line -1.52
MACD Signal Line -0.28
MACD Histogram -1.2366
Fundamentals Value
Market Cap 309.4 Million
Num Shares 455 Million
EPS 1.40
Price-to-Earnings (P/E) Ratio 48.57
Price-to-Sales 6.03
Price-to-Book 3.79
PEG Ratio 0.00
Dividend 0.01
Dividend Yield 0.01%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 72.99
Resistance 3 (R3) 73.55 72.44 72.16
Resistance 2 (R2) 72.44 71.17 72.16 71.88
Resistance 1 (R1) 70.22 70.38 69.66 69.66 71.61
Pivot Point 69.11 69.11 68.83 68.83 69.11
Support 1 (S1) 66.89 67.84 66.34 66.34 64.39
Support 2 (S2) 65.78 67.05 65.50 64.12
Support 3 (S3) 63.56 65.78 63.84
Support 4 (S4) 63.01